CDC42 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.998400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.867980E-01
Normal-vs-Stage2
4.102200E-01
Normal-vs-Stage3
2.252600E-01
Normal-vs-Stage4
4.490000E-01
Stage1-vs-Stage2
3.743000E-01
Stage1-vs-Stage3
8.948800E-01
Stage1-vs-Stage4
8.764000E-02
Stage2-vs-Stage3
3.723200E-01
Stage2-vs-Stage4
2.569200E-01
Stage3-vs-Stage4
1.532560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.918000E-01
Normal-vs-AfricanAmerican
8.536800E-01
Normal-vs-Asian
1.255800E-01
Caucasian-vs-AfricanAmerican
3.814600E-01
Caucasian-vs-Asian
2.050000E-01
AfricanAmerican-vs-Asian
1.385410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.732600E-01
Normal-vs-Female
5.695400E-01
Male-vs-Female
1.344380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.107200E-01
Normal-vs-Age(41-60Yrs)
7.693000E-01
Normal-vs-Age(61-80Yrs)
3.015800E-01
Normal-vs-Age(81-100Yrs)
5.417800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.840200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.460600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.251400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.018400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.888200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.842800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.934010E-01
Normal-vs-Daily Drinker
3.909200E-01
Normal-vs-Weekly Drinker
1.614780E-01
Normal-vs-Occasional Drinker
9.852200E-01
Normal-vs-Social Drinker
2.254400E-01
Non Drinker-vs-Daily Drinker
3.693400E-01
Non Drinker-vs-Weekly Drinker
9.677200E-01
Non Drinker-vs-Occasional Drinker
2.068300E-02
Non Drinker-vs-Social Drinker
6.681800E-01
Daily Drinker-vs-Weekly Drinker
4.601400E-01
Daily Drinker-vs-Occasional Drinker
1.422380E-01
Daily Drinker-vs-Social Drinker
6.938600E-01
Weekly Drinker-vs-Occasional Drinker
5.701900E-02
Weekly Drinker-vs-Social Drinker
7.136800E-01
Occasional Drinker-vs-Social Drinker
9.356300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.492400E-01
Normal-vs-Grade 2
7.153000E-01
Normal-vs-Grade 3
7.484600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.487600E-02
Grade 1-vs-Grade 3
1.368030E-01
Grade 1-vs-Grade 4
6.492400E-01
Grade 2-vs-Grade 3
5.078800E-01
Grade 2-vs-Grade 4
7.153000E-01
Grade 3-vs-Grade 4
7.484600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.783600E-01
Normal-vs-NonDiabetic
3.037000E-01
Diabetic-vs-NonDiabetic
8.108000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.084000E-01
Normal-vs-NoPancreatitis
3.762800E-01
Pancreatitis-vs-NoPancreatitis
8.041200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.647200E-01
Normal-vs-N1
4.879200E-01
N0-vs-N1
2.852200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.438600E-01
Normal-vs-TP53-NonMutant
1.664650E-01
TP53-Mutant-vs-TP53-NonMutant
3.376200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
